Beta-Glucan

Beta-Glucan

Global Beta-Glucan Market to Reach US$1.1 Billion by 2030

The global market for Beta-Glucan estimated at US$646.3 Million in the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Cereal-based Beta-Glucan, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$474.5 Million by the end of the analysis period. Growth in the Yeast-based Beta-Glucan segment is estimated at 7.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$180.4 Million While China is Forecast to Grow at 8.6% CAGR

The Beta-Glucan market in the U.S. is estimated at US$180.4 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$121.6 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.1% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

Global Beta-Glucan Market - Key Trends & Drivers Summarized

What Are Beta-Glucans, and Why Should You Care?

Beta-glucans are naturally occurring polysaccharides found in the cell walls of cereals, bacteria, and fungi, with oats and barley being particularly rich sources. These complex sugars are recognized for their ability to modulate the immune system, which makes them valuable in the medical field as well as in nutrition science. Beta-glucans are soluble fibers that not only help in managing cholesterol levels but also play a crucial role in controlling blood sugar, thereby providing an essential function in the management of diabetes and cardiovascular diseases. Beyond their health benefits, beta-glucans are used in various industries, including food production, where they act as texturizers and fat replacers, and in cosmetic formulations to improve skin hydration and reduce signs of aging.

How Are Beta-Glucans Changing the Landscape of Medical Research?

The therapeutic potential of beta-glucans has been a subject of intense research, particularly their role in cancer treatment and management. Studies have shown that beta-glucans can enhance the efficacy of anticancer therapies by boosting the body`s immune response to tumors. In the realm of infectious diseases, beta-glucans are studied for their potential to enhance the immune defenses against bacterial and viral infections, including as part of treatment regimens for conditions like HIV. Their ability to stimulate immune cells, such as macrophages and natural killer cells, positions them as a significant adjunct therapy in immune-compromised patients, offering a complementary approach alongside traditional treatments.

What Innovations Are Propelling the Beta-Glucan Market Forward?

In recent years, the market for beta-glucans has seen substantial innovation, particularly in the extraction and application technologies that enhance their purity and effectiveness. Advanced extraction methods, such as those using enzymes and ultrasonication, have improved the solubility and bioactivity of beta-glucans, making them more effective as dietary supplements and functional food ingredients. The cosmetics industry is also embracing beta-glucans, with increased use in formulations aimed at anti-aging, moisturizing, and protective skincare products. Furthermore, the rise of plant-based and functional foods has spurred the incorporation of beta-glucans into a wider range of consumer products, including dairy alternatives and bakery goods, which are being marketed not only for their health benefits but also for their role in enhancing texture and taste.

Here’s What’s Driving Growth in the Beta-Glucan Market

The growth in the beta-glucan market is driven by several factors, including heightened consumer awareness of health and wellness, which has amplified the demand for immune-boosting dietary supplements and functional foods. Technological advancements in extraction and processing have significantly lowered costs and improved the functional properties of beta-glucans, making them more appealing to food and beverage manufacturers. Additionally, the expanding vegan and vegetarian population globally fuels the demand for plant-based products enriched with beta-glucans. Another critical driver is the regulatory support for health claims related to beta-glucans in major markets, which aids in consumer acceptance and market growth. As lifestyles shift towards more health-conscious choices, the demand for products incorporating beta-glucans is expected to continue to rise, reflecting their growing role in a health-oriented global market.

Select Competitors (Total 48 Featured) -

• Kerry Group PLC
• MilliporeSigma
• Associated British Foods PLC
• Adeka Corporation
• Kemin Industries, Inc.
• Lallemand, Inc.
• Givaudan SA
• Innophos Holdings, Inc.
• Ceapro, Inc.
• Lesaffre Group
• Angel Yeast Co., Ltd.
• Lantmannen Group
• Leiber GmbH
• ArcticZymes AS
• Algalif Iceland EHF

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.